Tampa General Hospital (TGH) announced that is the first in Florida to use an organ care system that…
Articles by Ana Pena, PhD
Trikafta is expected to be a “game-changing” therapy for cystic fibrosis…
Patients with cystic fibrosis (CF) have a high prevalence of chronic kidney disease (CKD) linked to higher levels…
Three investigative therapies by Proteostasis Therapeutics — PTI-801, PTI-808, and PTI-428 — showed potential to treat…
The Government of Quebec, in Canada, has approved a loan of $2.7 million Canadian…
Pseudomonas aeruginosa, a bacteria that commonly causes serious lung infections in people with cystic fibrosis (CF),…
People with cystic fibrosis (CF) show a “high adherence” to CFTR modulators, but these newer medications are costly…
Latinos in the Caribbean with cystic fibrosis (CF) carry rare CFTR gene mutations not often seen in Latin…
Preclinical data shows that Arrowhead Pharmaceuticals‘ investigational inhaled treatment for cystic fibrosis (CF), called ARO-ENaC, accelerates mucus clearance…
Alaxia has joined the European consortium iABC to accelerate the development of ALX-009, an investigational inhaled antibiotic for…